MAPK1 and hepatocellular carcinoma: Overall, these results provide further evidence that downregulation of APN significantly reduced the phosphorylation of ERK, thereby reducing the rate of HCC tumor development in vivo, whereas overexpression of BCKDKS31D can effectively reverse this phenotype.